Newpark Resources, Inc.: Strong Performance in Energy Sectorby Mark Eisenberg 18.04.2024Discover the financial insights of Newpark Resources, Inc., a leading player in the Oil & Gas Equipment & Services industry. ...
Is the Stock Market Open Today? See Amended UK Trading Hoursby Terry Bingman 28.03.2024The London Stock Exchange (LSE) will have amended trading times during Easter 2024, with the market closing at 12:30pm. Morningstar's ...
LG Invests $74 Billion in AI, Biotech, Cleantechby Lilu Anderson 27.03.2024South Korean conglomerate LG Corp. plans to invest $10 billion in artificial intelligence and battery production for electric vehicles.
Roche’s Digital Health Chief Focuses on Teamworkby Lilu Anderson 23.02.2024The global head of digital health at Roche Pharma, Ranjan, highlights the potential for digital health technology to improve patient ...
HMEL Boosts Efficiency with iPlanSTO Technologyby Lilu Anderson 19.02.2024HMEL (India) partners with IAMTech (UK) to enhance strategic operations. The collaboration highlights HMEL's commitment to innovative technologies and stakeholder ...
Equinor signs long-term LNG deal with Deepak Fertilisersby Terry Bingman 19.02.2024Equinor has signed a 15-year deal to supply liquefied natural gas to Deepak Fertilisers in India. The agreement will provide ...
Alabama’s Gaming Bill: Vote on Legalized Gambling?by Mark Eisenberg 19.02.2024Residents of Alabama may soon have the opportunity to vote on legalized gambling for the first time in 25 years. ...
TotalEnergies Faces Challenges in Normandy Operationsby Lilu Anderson 16.02.2024TotalEnergies is resuming operations at its Normandy petrochemical site despite technical issues. Concerns over styrene availability have led to a ...
Vaccinex, Inc. Strategic Move: Impact on Nasdaq Complianceby Mark Eisenberg 15.02.2024Biotech company Vaccinex, Inc. plans a reverse stock split to meet Nasdaq's minimum bid price requirement and retain its listing. ...
Wolfe Research Bullish on Roivant Sciences: Outperform Ratingby Mark Eisenberg 15.02.2024Wolfe Research initiates coverage on Roivant Sciences, assigning an outperform rating with a price target of $17.00. Their analysis highlights ...